» Articles » PMID: 27795859

ATP Induces Disruption of Tight Junction Proteins Via IL-1 Beta-Dependent MMP-9 Activation of Human Blood-Brain Barrier

Overview
Journal Neural Plast
Specialty Neurology
Date 2016 Nov 1
PMID 27795859
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Disruption of blood-brain barrier (BBB) follows brain trauma or central nervous system (CNS) stress. However, the mechanisms leading to this process or the underlying neural plasticity are not clearly known. We hypothesized that ATP/P2X7R signaling regulates the integrity of BBB. Activation of P2X7 receptor (P2X7R) by ATP induces the release of interleukin-1 (IL-1), which in turn enhances the activity of matrix metalloproteinase-9 (MMP-9). Degradation of tight junction proteins (TJPs) such as ZO-1 and occludin occurs, which finally contributes to disruption of BBB. A contact coculture system using human astrocytes and hCMEC/D3, an immortalized human brain endothelial cell line, was used to mimic BBB . Permeability was used to evaluate changes in the integrity of TJPs. ELISA, Western blot, and immunofluorescent staining procedures were used. Our data demonstrated that exposure to the photoreactive ATP analog, 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate (BzATP), induced a significant decrease in ZO-1 and occludin expression. Meanwhile, the decrease of ZO-1 and occludin was significantly attenuated by P2X7R inhibitors, as well as IL-1R and MMP antagonists. Further, the induction of IL-1 and MMP-9 was closely linked to ATP/P2X7R-associated BBB leakage. In conclusion, our study explored the mechanism of ATP/P2X7R signaling in the disruption of BBB following brain trauma/stress injury, especially focusing on the relationship with IL-1 and MMP-9.

Citing Articles

Role of P ×  receptor during focused ultrasound induced blood brain barrier modulation.

Park J, Na Y, Lee J, Seo Y, Kim H, Han S Sci Rep. 2025; 15(1):965.

PMID: 39762398 PMC: 11704064. DOI: 10.1038/s41598-024-83913-3.


Tumor-derived extracellular vesicles disrupt the blood-brain barrier endothelium following high-frequency irreversible electroporation.

Murphy K, Aycock K, Marsh S, Hay A, Athanasiadi I, Bracha S Sci Rep. 2024; 14(1):28533.

PMID: 39557959 PMC: 11574144. DOI: 10.1038/s41598-024-79019-5.


Role of inflammasomes and neuroinflammation in epilepsy.

Hollis A, Lukens J Immunol Rev. 2024; 329(1):e13421.

PMID: 39523682 PMC: 11744240. DOI: 10.1111/imr.13421.


Neuroinflammatory responses and blood-brain barrier injury in chronic alcohol exposure: role of purinergic P2 × 7 Receptor signaling.

Togre N, Mekala N, Bhoj P, Mogadala N, Winfield M, Trivedi J J Neuroinflammation. 2024; 21(1):244.

PMID: 39342243 PMC: 11439317. DOI: 10.1186/s12974-024-03230-4.


Unveiling the hidden connection: the blood-brain barrier's role in epilepsy.

Han J, Wang Y, Wei P, Lu D, Shan Y Front Neurol. 2024; 15:1413023.

PMID: 39206290 PMC: 11349696. DOI: 10.3389/fneur.2024.1413023.


References
1.
Kimbler D, Shields J, Yanasak N, Vender J, Dhandapani K . Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice. PLoS One. 2012; 7(7):e41229. PMC: 3398891. DOI: 10.1371/journal.pone.0041229. View

2.
Amin A, Senga T, Oo M, Thant A, Hamaguchi M . Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk. Genes Cells. 2003; 8(6):515-23. DOI: 10.1046/j.1365-2443.2003.00652.x. View

3.
Hatherell K, Couraud P, Romero I, Weksler B, Pilkington G . Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods. 2011; 199(2):223-9. DOI: 10.1016/j.jneumeth.2011.05.012. View

4.
Wu C, Hsieh H, Sun C, Yang C . IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes. Glia. 2009; 57(16):1775-89. DOI: 10.1002/glia.20890. View

5.
Bryant R . Post-traumatic stress disorder vs traumatic brain injury. Dialogues Clin Neurosci. 2011; 13(3):251-62. PMC: 3182010. View